The chromatin associated transcription factor HMGA2 is a downstream target of let-7 miRNAs and binds to chromatin to regulate gene expression. Inhibition of let-7 miRNAs by RNA-binding proteins LIN28A and LIN28B is necessary during early embryogenesis to ensure stable expression of HMGA2. In addition to LIN28, HMGA2 is regulated by a BRCA1/ZNF350/CtIP repressor complex. In normal tissues, the BRCA1/ZNF350/CtIP complex binds to the HMGA2 promoter to prevent transcription. However, in many cancers the oncomiR miR-182 targets BRCA1, preventing BRCA1 translation and allowing for increased HMGA2. Little is known about the regulation of HMGA2 during early placental development; therefore, we hypothesized that both LIN28 and BRCA1 can regulate HMGA2 in placental cells. Using siRNA and CRISPR gene editing techniques, we found that knockdowns of both LIN28A and LIN28B increase HMGA2 levels in ACH-3P cells. These cells also demonstrated deficiencies in cell differentiation, seemingly differentiating solely towards the syncytiotrophoblast sublineage, secreting higher amounts of hCG, and displaying upregulated ERVW-1. Additionally, we found that a knockout of both LIN28A and LIN28B caused a significant increase of miR-182 and a decrease in BRCA1 allowing HMGA2 mRNA levels to increase and protein levels to remain the same. Using chromatin immunoprecipitation, we saw binding of the BRCA1 repressor complex to HMGA2. We also saw a decrease in binding to HMGA2's promoter in the LIN28A/B knockout cells. These findings suggest a novel role for BRCA1 during early human placental development.
Introduction
Trophoblast cells are the first cell lineage to differentiate during early embryonic development. These cells are found on the outside of the morula and differentiate to become the trophectoderm, surrounding the pluripotent cells of the inner cell mass at the blastocyst stage [1] . The differentiation of trophoblast cells into more specialized placental cell lineages is essential for proper development of the placenta. Anomalies in trophoblast cell differentiation can lead to placental pathologies, including preeclampsia and intrauterine growth restriction (IUGR) [2] [3] . IUGR affects approximately 5% of total pregnancies [4] with preeclampsia affecting 4% [5] . In addition to the immediate symptoms caused by placental dysfunction, including both fetal and maternal mortality, there are often long-term effects on human health, such as an increased probability to develop hypertension, coronary heart disease, and diabetes in adult life [6] [7] [8] . As there currently are no preventative measures available for either complication, further research is essential to elucidate the molecular events occurring in early placental development.
The Lin28-let-7-Hmga2 axis has been extensively studied in embryonic stem (ES) cells and is an important regulator of stem cell self-renewal [9] . LIN28 works through two distinct mechanisms to maintain pluripotency in ES cells, by regulating the biogenesis and maturation of the let-7 family of miRNAs and by modulating the translation of mRNAs important for maintaining an undifferentiated state [10] . LIN28 has two paralogs, LIN28A and LIN28B. Together they work to inhibit let-7 miRNA function by preventing processing into mature miRNAs [11] . Despite the similarity between the two paralogs, LIN28A and LIN28B work through two discrete pathways to inhibit miRNA processing. LIN28A, found in the cytoplasm, binds to pre-let-7's to prevent processing by Dicer. Once bound, LIN28A recruits the TUTase Zcchc11 to oligouridylate the pre-let-7, leading to rapid degradation of the transcript [12, 13] . Alternatively, LIN28B works independently of Zcchc11 by binding to and sequestering pri-let-7's within the nucleus preventing the processing by Drosha into pre-let-7 miRNA [14] .
One notable effect of the repression of let-7 miRNAs is on the expression of the high-mobility group AT-hook 2 (HMGA2). HMGA2 alters chromatin structure to activate many transcription factors important for retaining an undifferentiated state [15] . It is highly expressed during embryonic and fetal development before being repressed by let-7 miRNAs as embryonic cells begin to differentiate [16, 17] . Zhou et al. defined Hmga2 as the cause behind the pygmy phenotype in mice. Hmga2 −/-mutant mice have a reduced birth weight and an adult body weight of approximately 40% of what their wild-type counterparts weigh [18] . Furthermore, HMGA2-deficient embryonic fibroblasts have severe proliferation defects [19] . These data suggest that HMGA2 expression during embryonic development is essential for proper growth and development.
While the let-7 miRNAs have been more extensively studied, they are not the only method of silencing HMGA2 in normal cells. The tumor suppressor protein breast cancer susceptibility gene 1 (BRCA1) also negatively regulates HMGA2 expression. BRCA1 forms a repressor complex with CtBP-interacting protein (CtIP) and zinc finger protein 350 (ZNF350). This complex directly binds to a ZNF350 binding motif found on the promoter region of HMGA2 to inhibit transcription [20] . Removal of any one of these repressor proteins leads to increased expression of HMGA2 and tumorigenesis [20] . The oncomiR, miR-182, directly targets BRCA1 and decreases translation [21] . Furthermore, approximately 70% of advanced ovarian cancers have increased miR-182 and HMGA2 expression and decreased BRCA1 expression, suggesting that overexpression of miR-182 can promote HMGA2 expression in cancer cells [22] .
Both LIN28 and BRCA1 have been extensively characterized in breast and ovarian cancer cells. However, little is known about the regulation of HMGA2 during placental development. As early placental development mimics the hallmarks of cancer in a tightly controlled environment, we hypothesized that both LIN28 and BRCA1 are important regulators of cell differentiation in the placenta. To test this hypothesis, we used the immortalized trophoblast cell line, ACH-3P. The ACH-3P cell line was immortalized through the fusion of primary human first trimester trophoblast cells to the choriocarcinoma cell line AC1-1 [23] . These cells express high levels of cytokeratin-7 and virtually no vimentin, indicating that these cells are representative of trophoblast cells. They are also responsive to Forskolin, a stimulator of cAMP activity and trophoblast cell differentiation and fusion. Upon treatment with Forskolin, the ACH-3P cells secrete higher levels of human chorionic gonadotropin (hCG) and syncytializing [23] . These cells also display high levels of invasive potential when plated on several coating substrates, including Matrigel, Collagen, Fibronectin, and Laminin [24] . These data suggest that these cells can recapitulate cell differentiation in vitro. Furthermore, an shRNA knockdown of LIN28A in the human trophoblast ACH-3P cell line led to spontaneous syncytialization and differentiation [25] . However, upon analysis of both LIN28A and LIN28B levels, we found that the ACH-3P cells express higher levels of LIN28B than LIN28A (data not shown), resembling the expression pattern demonstrated in human placental tissue. Therefore, we used the ACH-3P cell line to further investigate how LIN28 regulates HMGA2 in placental cells.
HMGA2 has been found to localize to the undifferentiated trophoblast progenitor cells of the human placenta and becomes downregulated as these cells begin to differentiate [26] . Homozygous BRCA1 mutant mice are embryonic lethal by day E7.5, partially due to a poorly organized extraembryonic region. These mutants have a complete absence of diploid trophoblast cells with an inappropriate number of giant cells [27] . Interestingly, miR-182 has been reported as significantly upregulated in the placentas and serum of pre-eclamptic women compared to normotensive women [28, 29] . Collectively, these data suggest that regulation of HMGA2 may be a key regulator of cell differentiation during early human placental development. In this study, we describe the regulation of HMGA2 by LIN28B and BRCA1 in human placental cells for the first time.
Materials and methods

Cell lines
The immortalized ACH-3P (a gift from Ursula Hiden, Medical University of Graz, Austria) cell line was used for this study. ACH-3P cells were immortalized by fusion with the cell line AC1-1. ACH-3P cells were cultured in DMEM F-12 medium (HyClone), 10% FBS (HyClone), and 1% Penicillin/Streptomycin/Amphotericin (Corning Life Sciences).
Human first trimester placental samples
Human 6 (n = 3), 8 (n = 3), and 11.5 (n = 2) week placental samples were obtained from elective terminations from anonymous, nonsmoking, nondrug using patients in accordance with the protocol 10-1623H approved by the Colorado State University Institutional Review Board. Placental tissues were stored in phosphate-buffered saline upon collection. Some of these samples were then transferred to ice cold 4% paraformaldehyde (Fisher Scientific). After incubation overnight at 4
• C in paraformaldehyde, tissues were transferred to 70% ethanol and kept at 4
• C until paraffin embedding.
Other samples were frozen at -80 • C until used for cellular mRNA isolation. Real-time PCR
Total cellular RNA was isolated from tissue and cells using a RNA Mini Kit (Qiagen). Complementary DNA was generated from 1 μg total RNA using an iScript cDNA Synthesis Kit (Bio-Rad). Quantitative real-time PCR was conducted using SsoAdvanced Universal SYBR Green Supermix (Bio-Rad). The primer sequences used are displayed in Table 1 . For analysis, a PCR product for each gene was generated and cloned into the PCR-Script Amp SK(+) vector (Agilent Technologies). By amplifying the PCR product from each gene's plasmid, a standard curve was generated ranging from 1 × 10 2 to 1 × 10 −6 pg. The starting quantity (in picograms) was normalized against the starting quantity of RPS15 mRNA [30] . Quantitative real-time PCR was also conducted using Taqman Gene Expression Assays (Applied Biosystems). In 20 μL qPCR reactions that contained 10 μL SsoAdvanced Universal Probes Supermix (Bio-Rad), 1 μL of 150 nM Taqman Gene Expression Assay (ThermoFisher), and 9 μL of cDNA template diluted to 90 μL. Reactions were incubated at 95
• C for 10 min, then underwent 40 cycles of
95
• C for 30 s, 59
• C for 1 min, and 72
• C for 1 min using a LightCycler480 PCR System (Roche Applied Science). Probe efficiency was determined using serial dilutions from a cDNA pool from cell samples. Standard curves from the serial dilutions were analyzed, and efficiencies were calculated. Relative expression was normalized using GAPDH. Each reaction was conducted in triplicate using two controls, one RT control and one water control. Relative expression was determined for qPCR data using the comparative Ct method [31] . For miRNA analysis, total RNA was extracted using a miRNA Mini Kit (Qiagen). Complementary DNA was generated from 500 ng of total RNA using a miScript RT II kit (Qiagen). Real-time PCR was conducted using QuantiTect SYBR Green Master Mix (Qiagen), a miScript universal primer (Qiagen), a miScript primer assay for the mature let-7 or miR-182 miRNA sequence (Qiagen), and 1 μL of cDNA diluted to 3 ng. Reactions were incubated at 95
• C for 15 min, then 40 cycles of 94
• C for 15 s, 55
• C for 30 s, and 70
• C for 30 s. Relative expression of miRNA levels was normalized using SNORD48. Each reaction was conducted in duplicate using two controls, one RT control and one water control.
Immunofluorescence
Tissue was fixed for 24 h in 4% PBS paraformaldehyde at 4
• C, then dehydrated and embedded in paraffin wax. Five micron sections were mounted onto charged glass microscope slides (Premiere). Sections were deparaffinized and rehydrated in successive 4-min baths of Citrasolv (Decon Labs), 100% ethanol, 90% ethanol, 70% ethanol, 50% ethanol, and distilled water. Sections then underwent antigen retrieval using 10 mM sodium citrate buffer and microwaved for 10 min after being brought to a boil. Sections were rinsed three times with PBS then blocked at room temperature using 6% goat serum in PBS for 1 h. Sections were incubated in a humidity chamber overnight at 4
• C in antibodies 1:100 LIN28B, 1:100 HMGA2, 1:100 BRCA1, or 1:200 hCG (Table 1) . After washing three times in PBS, sections were incubated for 1 h at room temperature in 1:1000 goat anti-rabbit AlexaFluor 488 (Abcam, ab150077) or goat antimouse AlexaFluor 594 (Abcam, ab150092). After 1 h, slides were washed in PBS then dehydrated by successive baths of 50%, 70%, 90%, and 100% ethanol. Slides were then mounted with Prolong Gold containing DAPI (4 ,6-diamidino-2-phenylindole) (Life Technologies). For negative controls, normal rabbit sera was used as a primary antibody (Molecular Probes).
Western blot
Western blot analysis was used to assess cellular protein amounts. Each experiment was conducted with at least three replicates and repeated a minimum of three times. Cells were lysed in RIPA buffer (20 mM Tris, 137 mM NaCl, 10% glycerol, 1% nonidet P-40, 3.5 mM SDS, 1.2 mM sodium deoxycholate, 1.6 mM EDTA, pH 8) with 10% protease/phosphate inhibitor cocktail (Sigma-Aldrich) and 1 mM phenymethanesulfonyl fluoride. The BCA protein assay kit (Pierce) was used to determine protein concentration. Absorbance was measured at λ 595 nm using a Biotek Synergy 2 Microplate Reader (Biotek). Protein was electrophoresed in 12% Bis-Tris gels and transferred to 0.45-μm pore nitrocellulose membrane at 110 V at 4
• C for 1 h. Membranes were then blocked in 5% milk-TBST (50 mM Tris, 150 mM NaCl, 0.05% Tween 20, pH 7.6) for 1 h at room temperature then incubated with an antibody to LIN28B, LIN28A, HMGA2, or BRCA1 (Table 1) at 4
• C overnight. After overnight incubation, membranes were washed three times for 10 min each wash in TBST then incubated with a horseradish peroxidase-conjugated secondary antibody (1:1000, Abcam, ab6721) for 1 h at room temperature. Depending on protein size, an antibody for β-actin, α-tubulin, or GAPDH (Table 2 ) was used to normalize protein in cell lysates. Membranes were developed using ECL Western Blotting Detection Reagent chemiluminescent kit and membranes were imaged using a ChemiDoc XRS + chemiluminescence system (BioRad). Densitometry was performed using Image Lab (Bio-Rad). Fold change was calculated as a percent of control protein after normalization. 
LIN28A/B double knockout
Lentiviral particles targeting LIN28A and LIN28B were made from two separate plasmids. First, a lentiCRISPR v2 (Addgene) vector containing sgRNA for LIN28A (Oligo 1 -5 -CACCGCTGTCCATGACCGCCCGCGC -3 ; Oligo 2-5 -AAACGCGCGGGCGGTCATGGACAGC 3 ) was created. This vector was transformed into Stbl3 competent cells (ThermoFisher) and grown in LB broth. Plasmid DNA was isolated using a HiSpeed Plasmid Midi Kit (Qiagen). HEK cells were transfected using the lentiCRISPR v2 plasmid, a packaging plasmid (PAX), and an envelope plasmid (pMD2.G) in serum-free DMEM media at a total volume of 675 μL. Cells were transfected with plasmid mix, 180 μL transfection reagent Polyfect (Qiagen), and 15 mL of complete cell culture medium for 6 h before media was changed then media was collected 72 h later. The virus containing media was centrifuged to remove cell debris then ACH-3P cells were infected. To achieve a complete knockout of LIN28A, a second infection was required. A second lentiCRISPR v2 plasmid was created, this time containing sgRNA for LIN28B (Oligo 1 -5 -CACCGGCTGCCGGAGCCGGCAGAGG -3 ; Oligo 2 -5 AAACCCTCTGCCGGCTCCGGCAGCC -3 ). The plasmid and virus were grown in the same way as before. ACH-3P cells were infected and western blotting confirmed a complete knockout of both LIN28A and LIN28B. As a control, ACH-3P cells were infected with lentivirus containing an empty lentiCrispr v2 plasmid.
Enzyme-linked immunosorbent assay
LIN28B KD and scramble control ACH-3P cells were plated in sixwell culture dishes with 50,000 cells per well and three replicates per treatment. Cell culture medium (1.5 mL) was collected at 24, 48, and 72 h. Concentrations of hCG in the cell medium were quantified using an ELISA kit specific for beta-hCG (mouse monoclonal antihCG conjugated to horseradish peroxidase) (ALPCO Diagnostics, Cat # 25-HCGHU-E01). Each experiment was conducted with at least three replicates and conducted twice.
Invasion/migration assay
Cell invasion was determined using the 24-well 8.0 μm BioCoat Matrigel Invasion Assay System (Corning). Cells were labeled with CellTracker Green CMFDA dye (Invitrogen) and seeded at a density of 1 × 10 4 per well with serum-free media into the upper chamber of the system. As a control, cells were also seeded onto the uncoated Falcon FluoroBlok 24-Multiwell system (Corning). Bottom wells were filled with media containing 10% FBS and cells were incubated at 37 
Co-immunoprecipitation
Protein was extracted from cellular lysate in the same method as for western blotting. BRCA1 was immunoprecipitated using a polyclonal antibody (Santa Cruz, sc-1021) bound to SureBeads Protein G magnetic beads (Bio-Rad, 161-4023) in 50 μg of protein lysate. A polyclonal IgG antibody (Abcam, ab6721) was used as a negative control. After immunoprecipitation, the protein was loaded into a western blot gel and the previously described western blot protocol was followed using a ZNF350 antibody (Abcam, ab127895). This experiment was conducted with three replicates and conducted three times.
Chromatin immunoprecipitation
Chromatin immunoprecipitation (ChIP) was performed using the Abcam ChIP Kit (Abcam, ab500) following the manufacturer's protocol. Briefly, approximately 3 × 10 6 cells were collected and resuspended in formaldehyde diluted with PBS. Cells were sonicated using a BioRuptor for 10 min on high for 30 s on then 30 s off. ZNF350 was immunoprecipated using a ChIP grade antibody (Abcam, ab127895) in 10 μg of sample. A polyclonal IgG antibody (Abcam, ab6721) was used as a negative control. PCR and qPCR were performed for the region of the HMGA2 promoter predicted to contain the ZNF350 binding site. Genomic DNA and ChIP input DNA were used as positive controls for PCR. Each experiment was conducted with three replicates and repeated three times. 
6 Weeks 8 Weeks Figure 1 . LIN28 and HMGA2 in the human first trimester placenta. LIN28A and LIN28B mRNA (RT-qPCR) at 6 and 8 weeks of gestation in human placentae (n = 3) indicating that LIN28B is significantly higher than LIN28A during early placental development. Asterisks indicate P < 0.01. Error bars represent SEM. (A) 11.5 week human placenta (n = 2) stained for LIN28B (green) (B) and HMGA2 (C) (green), and imaged at ×20 magnification. Arrows indicate LIN28B and HMGA2 are localized in the cytotrophoblast based on hCG (red) immunolocalization.
Statistics
To determine significance, all experimental replicates were assayed in triplicate and a Student t-test was utilized to compare between LIN28B KD and scramble control and LIN28 A/B DKO and control ACH-3P cells. All statistics were determined using Prism 7 for Mac OS X (GraphPad Software). P values less than 0.05 were considered statistically significant.
Results
LIN28B and HMGA2 in the human first trimester placenta
Messenger RNA levels of LIN28A and LIN28B were examined in the human first trimester placenta using RT-qPCR. LIN28A levels were very low at both 6 and 8 weeks (average starting quantities were 0.00006 and 0.00014 pg, respectively). However, LIN28B was significantly higher at both timepoints ( Figure 1A ). This information led us to focus on LIN28B protein immunofluorescence. Immunofluorescent imaging was used on 11.5 week placentas to localize LIN28B and HMGA2 proteins. Both LIN28B ( Figure 1B ) and HMGA2 ( Figure 1C ) were exclusively detected in the cytotrophoblast, becoming undetectable in the differentiated syncytiotrophoblast stained positive for hCG.
Short hairpin RNA knockdown of LIN28B in the ACH-3P cell line
To examine the role of LIN28B in cytotrophoblast cells, ACH-3P cells were infected using lentivirus containing an shRNA construct specific for LIN28B. RT-qPCR and western blot revealed that there was a significant decrease in mRNA and protein in cells infected with the LIN28B shRNA compared to scrambled shRNA (Figure 2A and B). Immunocytochemistry confirmed that LIN28B protein was decreased in the LIN28B knockdown cells compared to scramble control cells ( Figure 2C ).
Knockdown of LIN28B drives differentiation to syncytiotrophoblast lineage
Knockdown of LIN28B significantly increased let-7a, let-7e, and let-7f miRNAs compared to scramble control cells (P < 0.05) ( Figure 3A) . Additionally, the syncytiotrophoblast marker ERVW-1 was significantly increased, whereas LGALS13 was decreased ( Figure 3B ). ELISA analysis of hCG secreted into cell media revealed that LIN28B knockdown cells secreted significantly more hCG into cell media at all timepoints ( Figure 3C ). Finally, invasion and migration of LIN28B knockdown cells were analyzed. There was no significant difference at any timepoint for cell invasion for the knockdown cells compared to control cells ( Figure 3D ). These data suggest that these cells are differentiating towards the syncytiotrophoblast lineage of the placenta but not towards the extravillous trophoblast lineage in the absence of LIN28B.
LIN28A and HMGA2 in LIN28B knockdown cells
RT-qPCR and western blotting were used to analyze the mRNA and protein levels of HMGA2 and LIN28A in LIN28B knockdown cells compared to scramble control cells. Both HMGA2 mRNA and protein were significantly upregulated ( Figure 4A and B) in LIN28B knockdown cells compared to scramble control cells. However, upon analysis of LIN28A, we found that both LIN28A mRNA and protein were significantly upregulated ( Figure 4C and D) in LIN28B knockdown cells compared to scramble control cells.
HMGA2 mRNA and protein in LIN82A/B double knockout cells
Using a lentiviral targeting method, we used CRISPR-Cas9 to knock out LIN28A and LIN28B in ACH-3P cells ( Figure 5A ). There were additional let-7 miRNAs significantly upregulated in LIN28A/B knockout cells compared to LIN28B KD, specifically the let-7s; let-7a, let-7e, let-7f, let-7g, and let-7i. (Figure 5B ). Real-time qPCR and western blotting were used to analyze HMGA2 mRNA and protein levels in the LIN28A/B knockout cells. HMGA2 ( Figure 5C ) was significantly higher. However, HMGA2 protein levels ( Figure  5D ) were not significantly different in the LIN28A/B knockout cells compared to control cells.
Knockdown of both LIN28A and LIN28B drives differentiation to syncytiotrophoblast lineage
Using RT-qPCR, we determined that the syncytiotrophoblast marker ERVW-1 was significantly increased, whereas LGALS13 was decreased in the LIN28A/B knockout cells compared to controls ( Figure 6A and B) . ELISA analysis of hCG secreted into cell media revealed that LIN28A/B knockout cells secreted significantly more hCG (P < 0.005) into cell media at timepoints 24, 48, and 72 h ( Figure 6C ). Analysis of cell invasion indicated that the LIN28 A/B knockout cells were not significantly more invasive compared to control cells ( Figure 6D ), again indicating that these cells are acting more like syncytiotrophoblast cells but not extravillous trophoblast.
BRCA1 complexes with ZNF350 and binds to HMGA2
To investigate the increase in HMGA2 upon downregulation of LIN28A and LIN28B, we examined alternate mechanisms for regulation of HMGA2 transcription. Co-immunoprecipitation and chromatin immunoprecipation were used to determine if BRCA1 forms a complex with ZNF350 in trophoblast cells. Using ACH-3P cells, co-immunoprecipitation and subsequent western blotting revealed that BRCA1 complexes with ZNF350 ( Figure 7A ). As ZNF350 is the protein in the BRCA1 repressor complex that binds to the HMGA2 promoter, we used chromatin immunoprecipitation to determine if this complex binds to HMGA2 in ACH-3P cells. We found that ZNF350 binds to the ZNF350 recognition site in the HMGA2 promoter region as evidenced by PCR following chromatin immunoprecipitation ( Figure 7B ). Using immunofluorescence we determined that BRCA1 was localized solely in the synyctiotrophoblast of the human 11.5 week placenta ( Figure 7C ) suggesting that as cells differentiate, BRCA1 becomes upregulated.
MiR-182 and BRCA1 in LIN28B knockdown and LIN28A/B knockout cells
Because miR-182 regulates BRCA1 translation leading to increased HMGA2, we analyzed miR-182 levels in the LIN28A/B knockout cells. Using RT-qPCR, we analyzed miR-182 miRNA levels in the LIN28B knockdown and LIN28A/B knockout cells. MiR-182 was not significantly increased in the LIN28B knockdown cells ( Figure 8A ), potentially due to the upregulation of LIN28A. However, in the LIN28A/B knockout cells, miR-182 was significantly higher compared to control cells ( Figure 8B ). Similarly, in the LIN28B knockdown cells BRCA1 was not significantly decreased ( Figure 8C ). However, when we analyzed BRCA1 in the LIN28A/B knockout cells, we did see a significant decrease ( Figure 8D ). We also used chromatin immunoprecipitation and qPCR to determine if there was a decrease in the BRCA1 repressor complex to the promoter of HMGA2. Quantitative PCR determined that there was a significant decrease of binding to the HMGA2 promoter in the LIN28A/B DKO cells ( Figure 8E ). This removal of the BRCA1 repressor complex would allow for greater transcription of HMGA2.
Discussion
HMGA2 is known for its promotion of cell proliferation and growth during embryonic development [32] . HMGA2 also promotes cancer growth and tumorigenesis as transgenic expression of HMGA2 in mice led to the formation of benign tumors [33, 34] . In ES cells and many cancers, LIN28A and LIN28B block the biogenesis of the let-7 family of miRNAs maintaining self-renewal properties [35] [36] [37] [38] [39] . This LIN28-let7-HMGA2 axis has been described extensively in cancer. However, for the first time, we describe LIN28 in the maintenance of HMGA2 expression and cell differentiation in human placental cells. In summary, we have shown that upon deletion of LIN28A and LIN28B in human trophoblast cells, HMGA2 levels are unaffected, potentially due to the downregulation of BRCA1 caused by increased miR-182. This results in HMGA2 levels that cannot be downregulated by let-7 miRNA. There are no reports of miR-182 levels increasing upon the loss of LIN28 function but, interestingly, miR-182 has been reported to be elevated in the placentas of preeclamptic women [29] . As both LIN28 and HMGA2 are important regulators of cell differentiation, perhaps this upregulation of miR-182 serves as a rescue of HMGA2 function for a placenta in the early stages of distress. Therefore we propose a model in which we believe HMGA2 is regulated by the BRCA1 repressor complex during trophoblast differentiation into syncytiotrophoblast cells (Figure 9 ).
By inducing a knockdown of LIN28B protein, we found that LIN28B is necessary for keeping placental cells in a progenitorlike state. The syncytiotrophoblast marker ERVW1 and hCG secretion into culture media was significantly increased. The trophoblast marker LGALS13 was decreased in cells and there was no increase in cell invasion. This suggests that a knockdown of LIN28B negatively affects differentiation towards the extravillous trophoblast lineage. Surprisingly, we found that a loss of LIN28B protein led to increased HMGA2 although there was an increase in some of the let-7s. This increase in HMGA2 is explained by increased LIN28A protein levels. Wilbert et al. reported that an shRNA induced knockdown of LIN28A caused an increase of LIN28B in human ES cells [40] , suggesting that the two paralogs can compensate for a loss of function of the other protein.
However, when we used a lentiCRISPR targeting vector to knock out both LIN28A and LIN28B, we again found that, despite increasing levels of let-7 miRNA, HMGA2 mRNA is significantly higher than control cells. The increase of HMGA2 could be explained by increased miR-182 levels in the LIN28A/B knockout cells. When miR-182 is elevated, there is a reduction of the BRCA1/CtIP/ZNF350 repressor complex binding allowing for increased HMGA2 transcription [20] . Our findings that BRCA1 is downregulated in the LIN28A/B knockout cells suggest that this reduction of the BRCA1 Downloaded from https://academic.oup.com/biolreprod/article-abstract/100/1/227/5076026 by OUP site access user on 18 March 2019 Figure 9 . Proposed model of HMGA2 in human placental development. During early placental development, miR-182 levels are high to prevent translation of BRCA1, leading to high HMGA2 levels. Once cells begin to differentiate into syncytiotrophoblast cells, miR-182 levels decrease, allowing for formation of a BRCA1/CtIP/ZNF350 repressor complex that binds to the promoter region of HMGA2, preventing transcription. In pre-eclampsia, we postulate that miR-182 levels remain high upon differentiation leading to low BRCA1 and high HMGA2 transcription, causing impaired cell differentiation.
repressor complex is happening in placental cells. This was confirmed by a significant decrease in the binding of ZNF350 to the promoter region of HMGA2 in our LIN28A/B knockout cells. Decreased BRCA1 could cause increased HMGA2 transcription in the event of aberrant LIN28 expression during placentation. Therefore, we propose a novel role for miR-182 in the regulation of HMGA2 expression to prevent cell differentiation in the human placenta. This complex formation has been reported in mammary tumorigenesis [20] . However, to our knowledge, there have been no reports of a BRCA1 repressor complex targeting HMGA2 in trophoblast differentiation ( Figure 9) . Interestingly, even though HMGA2 mRNA levels increased, we did not observe a change in protein levels. LIN28 is a key regulator of cell differentiation, and can stimulate differentiation in progenitor cells [41] . This initiation of differentiation is thought to be a LIN28/let-7-independent event, relying on LIN28's ability to bind messenger RNA's important for self-renewal and differentiation [42] . One of these LIN28 targets are the family of insulinlike growth factor 2 binding proteins (IMPs). [43] . LIN28 stabilizes IMP1 and IMP3 levels, leading to higher levels of HMGA2 [44] . By altering LIN28's ability to stabilize the IMP family, we potentially affected the IMP family's ability to sequester the let-7s. This could explain why we failed to see increased levels of all let-7s in our LIN28 double knockout cells. Additionally, this could further explain why there were discrepancies between increased HMGA2 and unaltered levels of protein. The relationship between LIN28 and the IMPs is a relatively new finding and the mechanisms of how IMP and LIN28 regulate differentiation will need to be further elucidated in future studies. Finally, as placental insufficiency is a multifaceted disorder, we recognize that the BRCA1 repressor complex could potentially regulate many different aspects of this disorder. In addition to HMGA2, the BRCA1/CtIP/ZNF350 complex also regulates the transcription of the angiogenic factor, Angiopoietin 1 (ANG-1) [45] . An ovine model for fetal growth restriction reported that ANG-1 mRNA is significantly increased at D55 of gestational age before stabilizing at D90 and D135 compared to controls. Hagen et al. stated that this increase in ANG-1 might be an adaptive response to a pregnancy in distress [46] . Angiogenesis is an essential component of placentation and altered vasculature is a factor in most placental insufficiency pathologies. Future studies will involve investigating how BRCA1 regulates ANG1 in placental cells to further elucidate how this pathway is regulating early placental development. MicroRNAs have been suggested as potential biomarkers for diagnosis of placental dysfunction as they are relatively stable and easily found in maternal serum [47, 48] . Based on the previous knowledge of miR-182's aberrant expression in the serum and placentas of pre-eclamptic women and our findings of the role of miR-182 in promoting HMGA2 expression, we propose that miR-182 could potentially be a successful therapeutic biomarker for the early detection of placental dysfunction.
